Evidence map›Paper›PMID 27459400›Full record

ArticleCancer2016

Tobacco assessment in completed lung cancer treatment trials.

Erica N Peters, Graham W Warren, Jeff A Sloan, James R Marshall

Abstract read
In one paragraph

Article in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network Trials.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Erica N PetersBattelle Public Health Center for Tobacco Research, Baltimore, Maryland. finan@battelle.org.
Graham W WarrenDepartment of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina.
Jeff A SloanResearch Faculty, Mayo Clinic, Rochester, Minnesota.
James R MarshallDepartment of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York.
Roswell Park Comprehensive Cancer Center · USMedical University of South Carolina · USWinnMed · US

Funding

Collaborations and NCORP Collective ManagementUG1CA189823 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis, Olwen Hahn · 2014 to 2026
$120.6M
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareU10CA180867 · NCI · DANA-FARBER CANCER INST · PI BURSTEIN, HAROLD JOHN, KIBEL, ADAM S · 2014 to 2018
$6.2M
NCI NIH HHS U10 CA180867NCI NIH HHS UG1 CA189823
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansLung NeoplasmsSmokingSmoking CessationTobacco Products

Identifiers

PMID27459400
PMCPMC5338464
OpenAlexW2509519980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.